Trial results supported recent FDA approval for patients with relapsed/refractory disease HOUSTON ― Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel anti-CD19 chimeric antigen receptor (CAR) T cell therapy, obecabtagene autoleucel (obe-cel), experienced high […]
City of Houston Live
City of Katy katy
This player embeds official streams. If the live feed is offline, use the source link to view updates.
Browse previous videos
City of Houston Live
City of Houston – HTV Live houston
This player embeds official streams. If the live feed is offline, use the source link to view updates.
Browse previous videos
Contact The Katy News
Have a news tip, story idea, advertising question, or community announcement?
The Katy News
Serving Katy and the surrounding communities
General Inquiries: info@thekatynews.com
Advertising: ads@thekatynews.com
Article Submissions: articles@thekatynews.com
Phone: 281-396-3333
Follow Us
Copyright © The Katy News
